Materials and Methods: The patients were randomly assigned to receive subcutaneous tirzepatide once a week at doses of 1, 5, 10, or 15 mg, dulaglutide at a dose of 1.5 mg, or a placebo
But for those dealing with medication loads, alcohol consumption, environmental exposures, or metabolic stress, these compounds offer measurable support for specific hepatic functions
We expect more details from CMS in May and June, so stay tuned to OAC and OCAN resources for guidance on how providers can navigate prior authorization
The clinical trials are robust in their design, but they did not further explore the cause of the hair loss reported by some users of Wegovy
Pre-treatment with 10 M compound C significantly decreased the sub-G1 fraction in cells incubated with MG (Fig